Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
22:10
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

WFH 2014 World Congress

 

11-15 May 2014 Melbourne
FAQs
   
Discussion forum - WFH 2014 World Congress
    Topic - Prophylaxis

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Discontinuing long-term prophylaxis in severe haemophilia: effects on joint health  Annelies Nijdam 1      5/7/2014 3:40:00 PM  
Identifying prophylactic regimens in young children with Heamophilia A  Annelies Nijdam 1      5/7/2014 3:29:00 PM  
Changing views on the use of prophylaxis in men with severe hemophilia across the age spectrum  Shannon Jackson 1      5/6/2014 1:31:00 AM  
Individualization of prophylaxis in adults improves bleeding outcomes  K McIntosh 1      5/6/2014 1:25:00 AM  
EFFICACY OF ANKAFERD BLOOD STOPER (ABS) IN PROPHYLAXIS AND TREATMENT OF ORAL MUCOSITIS IN PEDIATRIC MALIGNANCIES: A PILOT STUDY  Turkan PATIROGLU 1      5/4/2014 5:58:00 PM  
Superiority of Prophylaxis vs On-Demand Therapy With Plasma Protein-Free Recombinant Factor VIII Formulated with Sucrose (BAY 81-8973): LEOPOLD II Study Results  Kaan Kavakli 1      4/25/2014 9:01:00 PM  
Association of Peak FVIII Levels and AUC with Bleeding in Patients with Hemophilia A on Every Third Day PK-Tailored Prophylaxis  Leonard Valentino 1      4/24/2014 12:30:00 AM  
Low Bleeding Rates in Youth and Young Adults on Low-Dose Daily Prophylaxis for Severe Hemophilia A.  Jean St-Louis 1      4/23/2014 4:38:00 PM  
Population pharmacokinetics of plasma-derived factor IX  Ari Brekkan Viggosson 1      4/22/2014 4:16:00 PM  
Factors associated with prophylaxis use in persons with hemophilia in the United States  Megan Ullman 1      4/22/2014 12:53:00 AM  
Retrospective analysis of 115 patients with haemophilia A in a single medical centre  Gonul Aydogan 1      4/9/2014 11:36:00 AM  
RESULTS OF EFFICACY AND SAFETY IN CLINICAL TRIAL ESTIMATED A NEW RECOMBINANT FACTOR VIII (OCTOFACTOR) IN PROPHILACTIC TREATMENT IN PATIENTS WITH SEVERE AND MODERATE HEMOPHILIA A.  Igor Davydkin 1      3/28/2014 9:09:00 AM  
Secondary Prophylaxis in Childhood Factor VII Deficiency  Zafer Salcioglu 1      3/28/2014 7:21:00 AM  
Low-dose prophylaxis for Chinese hemophilia children involving maxillary hemophilic pseudotumors  Guoxia Yu 1      2/27/2014 5:18:00 PM  
       




Most viewed poster for this congress
Poster: 1
Visits: 2526
Title: A WEB SITE TO IMPROVE MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT: RESULTS AT 2 YEARS
Authors: Annarita Tagliaferri ,
Centre: Centro di Riferimento Regionale per la cura dellEmofilia

Poster most viewed in this topic
Poster: 1
Visits: 444
Title: Superiority of Prophylaxis vs On-Demand Therapy With Plasma Protein-Free Recombinant Factor VIII Formulated with Sucrose (BAY 81-8973): LEOPOLD II Study Results
Authors: Kaan Kavakli , Renchi Yang, Luminita Rusen, Horst Beckmann, Despina Tseneklidou-Stoeter, Monika Maas Enriquez
Centre: Ege University, Childrens Hospital


 








PosterSessionOnline
Logo Draft
 
Logo Cert